# Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma

> **NCT03319537** · PHASE1,PHASE2 · TERMINATED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 9 (actual)

## Conditions studied

- Mesothelioma

## Interventions

- **DRUG:** pevonedistat
- **DRUG:** Pemetrexed and cisplatin

## Key facts

- **NCT ID:** NCT03319537
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-05
- **Primary completion:** 2023-06-05
- **Final completion:** 2023-06-05
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Sponsor terminated study agreement
- **Last updated:** 2024-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03319537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03319537, "Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03319537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*